SYSTEMEDICAL was formed in 2000 by Dr. William Norberg as a for-profit research and product development corporation to investigate alternative therapeutics in the field of critical care. SYSTEMEDICAL has researched, investigated and developed forumulations for the treatment of ischemic stroke and a modified human serum albumin.